UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say staff-driven ideas protect research independence in industry partnerships.
|Slideshows|January 13, 2019
- Managed Healthcare Executive January 2019 Issue
- Volume 29
- Issue 1
Top 9 Most Exciting Drugs in the 2019 Pipeline
Author(s)Nicholas Hamm
A look at what could be some of the biggest and most important drugs of the year.
Advertisement
Articles in this issue
almost 8 years ago
Top 4 Challenges Healthcare Executives Face in 2019almost 8 years ago
Philadelphia HIE Fosters Collaboration Among Competitoralmost 8 years ago
Top 6 Pharmacy Challenges of 2019almost 8 years ago
Six Ways Health Execs Can Advance Their Careers More Quicklyalmost 8 years ago
Top Healthcare Changes Associated with Urban Growthalmost 8 years ago
Telehealth Program Reduces ReadmissionsAdvertisement
Related to this article
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say research justifies services and opens doors to limited distribution drugs.
As the pharmacist pipeline tightens, leaders from UC Davis Health, UCSF Health, and Sutter Health say financial sustainability now depends as much on capacity as on cost.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Apothecary Pharma recalls compounded tirzepatide and NAD+ vials over sterility concerns
2
More checks in the plus column for GLP-1s for obstructive sleep apnea | CHEST 2026
3
Rex Hoffman, M.D., on physician burnout and collaborative leadership | HSES 2026
4
Rex Hoffman, M.D., on how a CMO balances competing priorities | HSES 2026
5